APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dasatinib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dasatinib Drugs Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchDasatinib Drugs Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Dasatinib Drugs Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Dasatinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dasatinib Drugs Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Dasatinib Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Dasatinib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dasatinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dasatinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dasatinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dasatinib Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dasatinib Drugs market include LUCIUS Pharma and Bristol-Myers Squibb among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dasatinib Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dasatinib Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dasatinib Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dasatinib Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Dasatinib Drugs Segment by Company

LUCIUS Pharma

Bristol-Myers Squibb

Dasatinib Drugs Segment by Type

70mg

50mg

20mg

Dasatinib Drugs Segment by Application

CML

ALL

Dasatinib Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Dasatinib Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dasatinib Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dasatinib Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Dasatinib Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dasatinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dasatinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dasatinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dasatinib Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dasatinib Drugs industry.

Chapter 3: Detailed analysis of Dasatinib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dasatinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dasatinib Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dasatinib Drugs Industry Trends Table 2. Dasatinib Drugs Industry Drivers Table 3. Dasatinib Drugs Industry Opportunities and Challenges Table 4. Dasatinib Drugs Industry Restraints Table 5. Global Dasatinib Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dasatinib Drugs Revenue Share by Company (2021-2026) Table 7. Global Dasatinib Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Dasatinib Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Dasatinib Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Dasatinib Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dasatinib Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Dasatinib Drugs Company, Product Type & Application Table 13. Global Dasatinib Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dasatinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 70mg Table 18. Significant Companies of 50mg Table 19. Significant Companies of 20mg Table 20. Global Dasatinib Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Dasatinib Drugs Sales Volume by Type (2021-2026) & (k units) Table 22. Global Dasatinib Drugs Sales Volume by Type (2027-2032) & (k units) Table 23. Global Dasatinib Drugs Sales Volume Share by Type (2021-2026) Table 24. Global Dasatinib Drugs Sales Volume Share by Type (2027-2032) Table 25. Global Dasatinib Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Dasatinib Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Dasatinib Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Dasatinib Drugs Sales Value Share by Type (2021-2026) Table 29. Global Dasatinib Drugs Sales Value Share by Type (2027-2032) Table 30. Significant Companies of CML Table 31. Significant Companies of ALL Table 32. Global Dasatinib Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Dasatinib Drugs Sales Volume by Application (2021-2026) & (k units) Table 34. Global Dasatinib Drugs Sales Volume by Application (2027-2032) & (k units) Table 35. Global Dasatinib Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Dasatinib Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Dasatinib Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Dasatinib Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Dasatinib Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Dasatinib Drugs Sales Value Share by Application (2021-2026) Table 41. Global Dasatinib Drugs Sales Value Share by Application (2027-2032) Table 42. Global Dasatinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Dasatinib Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Dasatinib Drugs Sales Market Share by Region (2021-2026) Table 45. Global Dasatinib Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Dasatinib Drugs Sales Market Share by Region (2027-2032) Table 47. Global Dasatinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dasatinib Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Dasatinib Drugs Sales Value Share by Region (2021-2026) Table 50. Global Dasatinib Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Dasatinib Drugs Sales Value Share by Region (2027-2032) Table 52. Global Dasatinib Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Dasatinib Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Dasatinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Dasatinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Dasatinib Drugs Sales by Country (2021-2026) & (k units) Table 57. Global Dasatinib Drugs Sales Market Share by Country (2021-2026) Table 58. Global Dasatinib Drugs Sales by Country (2027-2032) & (k units) Table 59. Global Dasatinib Drugs Sales Market Share by Country (2027-2032) Table 60. Global Dasatinib Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Dasatinib Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Dasatinib Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Dasatinib Drugs Sales Value Market Share by Country (2027-2032) Table 64. LUCIUS Pharma Company Information Table 65. LUCIUS Pharma Business Overview Table 66. LUCIUS Pharma Dasatinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. LUCIUS Pharma Dasatinib Drugs Product Portfolio Table 68. LUCIUS Pharma Recent Development Table 69. Bristol-Myers Squibb Company Information Table 70. Bristol-Myers Squibb Business Overview Table 71. Bristol-Myers Squibb Dasatinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Bristol-Myers Squibb Dasatinib Drugs Product Portfolio Table 73. Bristol-Myers Squibb Recent Development Table 74. Key Raw Materials Table 75. Raw Materials Key Suppliers Table 76. Dasatinib Drugs Distributors List Table 77. Dasatinib Drugs Customers List Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Dasatinib Drugs Product Image Figure 2. Global Dasatinib Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dasatinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dasatinib Drugs Sales (2021-2032) & (k units) Figure 5. Global Dasatinib Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Dasatinib Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 70mg Image Figure 10. 50mg Image Figure 11. 20mg Image Figure 12. Global Dasatinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Dasatinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Dasatinib Drugs Sales Volume Share by Type (2021-2032) Figure 15. Global Dasatinib Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Dasatinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Dasatinib Drugs Sales Value Share by Type (2021-2032) Figure 18. CML Image Figure 19. ALL Image Figure 20. Global Dasatinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Dasatinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Dasatinib Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Dasatinib Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Dasatinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Dasatinib Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Dasatinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Dasatinib Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Dasatinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Dasatinib Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Dasatinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Dasatinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Dasatinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Dasatinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Dasatinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Dasatinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Dasatinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Dasatinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Dasatinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Dasatinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Dasatinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Dasatinib Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Dasatinib Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 70mg
  • 50mg
  • 20mg
Applications
  • CML
  • ALL
Companies covered
  • LUCIUS Pharma
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dasatinib Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Dasatinib Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Dasatinib Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dasatinib Drugs Market Dynamics
  1. 2.1 Dasatinib Drugs Industry Trends
  2. 2.2 Dasatinib Drugs Industry Drivers
  3. 2.3 Dasatinib Drugs Industry Opportunities and Challenges
  4. 2.4 Dasatinib Drugs Industry Restraints
3 Dasatinib Drugs Market by Company
  1. 3.1 Global Dasatinib Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Dasatinib Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Dasatinib Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Dasatinib Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Dasatinib Drugs Company Ranking (2024-2026)
  6. 3.6 Global Dasatinib Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Dasatinib Drugs Company Product Type and Application
  8. 3.8 Global Dasatinib Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dasatinib Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dasatinib Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dasatinib Drugs Market by Type
  1. 4.1 Dasatinib Drugs Type Introduction
  2. 4.1.1 70mg
  3. 4.1.2 50mg
  4. 4.1.3 20mg
  5. 4.2 Global Dasatinib Drugs Sales Volume by Type
  6. 4.2.1 Global Dasatinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Dasatinib Drugs Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Dasatinib Drugs Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Dasatinib Drugs Sales Value by Type
  10. 4.3.1 Global Dasatinib Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Dasatinib Drugs Sales Value by Type (2021-2032)
  12. 4.3.3 Global Dasatinib Drugs Sales Value Share by Type (2021-2032)
5 Dasatinib Drugs Market by Application
  1. 5.1 Dasatinib Drugs Application Introduction
  2. 5.1.1 CML
  3. 5.1.2 ALL
  4. 5.2 Global Dasatinib Drugs Sales Volume by Application
  5. 5.2.1 Global Dasatinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Dasatinib Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Dasatinib Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Dasatinib Drugs Sales Value by Application
  9. 5.3.1 Global Dasatinib Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Dasatinib Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Dasatinib Drugs Sales Value Share by Application (2021-2032)
6 Dasatinib Drugs Regional Sales and Value Analysis
  1. 6.1 Global Dasatinib Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dasatinib Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Dasatinib Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Dasatinib Drugs Sales by Region (2027-2032)
  5. 6.3 Global Dasatinib Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dasatinib Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dasatinib Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dasatinib Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Dasatinib Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dasatinib Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Dasatinib Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dasatinib Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Dasatinib Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dasatinib Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dasatinib Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dasatinib Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Dasatinib Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dasatinib Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dasatinib Drugs Sales Value Share by Country, 2025 VS 2032
7 Dasatinib Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Dasatinib Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dasatinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dasatinib Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Dasatinib Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Dasatinib Drugs Sales by Country (2027-2032)
  6. 7.4 Global Dasatinib Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dasatinib Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dasatinib Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dasatinib Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dasatinib Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dasatinib Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 LUCIUS Pharma
  2. 8.1.1 LUCIUS Pharma Company Information
  3. 8.1.2 LUCIUS Pharma Business Overview
  4. 8.1.3 LUCIUS Pharma Dasatinib Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 LUCIUS Pharma Dasatinib Drugs Product Portfolio
  6. 8.1.5 LUCIUS Pharma Recent Developments
  7. 8.2 Bristol-Myers Squibb
  8. 8.2.1 Bristol-Myers Squibb Company Information
  9. 8.2.2 Bristol-Myers Squibb Business Overview
  10. 8.2.3 Bristol-Myers Squibb Dasatinib Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bristol-Myers Squibb Dasatinib Drugs Product Portfolio
  12. 8.2.5 Bristol-Myers Squibb Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dasatinib Drugs Value Chain Analysis
  2. 9.1.1 Dasatinib Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dasatinib Drugs Sales Mode & Process
  6. 9.2 Dasatinib Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dasatinib Drugs Distributors
  9. 9.2.3 Dasatinib Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst